ATCOR

ATCOR is now CONNEQT Health. Driving the future of arterial health. Follow @conneqthealth for updates across home, clinical, and research innovation. ASX:CQT

[Cardiex Limited @CardiexLimited]

Watch Cardiex's Chief Strategy Officer @catliao discuss the future of women's health data at #SensorsConverge2024! Discover how femtech is closing the data gap and driving innovation. 📊👩‍🔬 $CDX #FemTech #WomenInTech #HealthData #CardieX @FierceElectron https://t.co/98idDhC7MC

[Cardiex Limited @CardiexLimited]

Next week, if you're attending @SensorsConverge in Santa Clara, CA, don't miss Cardiex Chief Strategy Officer @catliao during The Future of Connected Wearables panel session. $CDX #connectedwearables #wearabletech #cardiex

[Cardiex Limited @CardiexLimited]

Stop by booth #1016 at DIA to learn how Cardiex’s digital vascular biomarkers enhance health & well-being. Plus, get a complimentary arterial health assessment! $CDX #DIA2024 #digitalvascularbiomarkers #healthtech #vascularhealth

[Cardiex Limited @CardiexLimited]

The results are in! We're proud to announce the winners of the Cardiex Arterial Research Initiative. Check out the innovative projects from our Winners and Voter Spotlight Honorees: https://t.co/tGcHG7K7W1

$CDX #CARI24 #CardiexResearch #Innovation #CardiovascularHealth

[Cardiex Limited @CardiexLimited]

The Cardiex team will be at the NAA Conference in Aurora, CO, June 14-15! Discover how our digital vascular biomarkers can transform healthcare and clinical research by helping to prevent early vascular aging. $CDX #NAA2024 #digitalvascularbiomarkers

[Cardiex Limited @CardiexLimited]

Don’t miss the chance to cast your Vote in the Cardiex Arterial Research Initiative! This is your opportunity to explore innovative proposals and support the research that could revolutionize arterial health. $CDX Visit our voting page before June 10: https://t.co/k0Y9clxBZp

[Cardiex Limited @CardiexLimited]

Only one day is left to visit Booth #522 and connect with the Cardiex team for your complimentary arterial assessment. Discover our gold-standard FDA-cleared solutions powered by SphygmoCor® technology that cover all your arterial assessment needs. $CDX #digitalvascularbiomarkers

[Cardiex Limited @CardiexLimited]

We are thrilled to unveil the 12 Finalists of our inaugural Cardiex Arterial Research Initiative. We are entering the voting phase, where the top 3 winners will be determined by popular vote among their peers. Vote now! $CDX https://t.co/gB94rh6Nxf

[Cardiex Limited @CardiexLimited]

Join the Cardiex team at ACSM 2024 in Boston! Discover how our digital vascular biomarkers enhance performance outcomes and customize exercise and therapy for athletes, clinical research, and healthcare. Visit us at booth #522 to learn more! $CDX #ACSM2024 #Cardiex #HealthTech

[Cardiex Limited @CardiexLimited]

On #ClinicalTrialsDay we honor the scientists, researchers, healthcare professionals and study participants, especially those we work with daily. Your contributions are critical in determining the safety and effectiveness of new treatments. $CDX Read more: https://t.co/JI1FkGJCAh

[ATCOR @AtcorMedical]

RT @CardiexLimited: On 5/23 @ 10 AM PT, don't miss Heart Talks: Navigating Vascular Age for Heart Health. This session will explore the com…

[Investing News Network Australia (INN) @INN_Australia]

In the #medicaltechnology industry, innovation is only the first step. Once a #technology has been developed and proven, the organization must then embark on a process to commercialize it for revenue generation. @CardieXLimited #investing https://t.co/X7gt0532sw

[Cardiex Limited @CardiexLimited]

Join the waitlist and be one of the first to experience the Pulse, a world's-first vascular biometric monitor at: https://t.co/2KNiKyJMaD $CDX

[Cardiex Limited @CardiexLimited]

Update! Our CONNEQT Pulse is now listed on the Validated Device List (VDL), a registry maintained by clinical stakeholders that validate blood pressure monitoring devices according to rigorous standards to ensure their accuracy and reliability. $CDX More: https://t.co/ZKQdhpoxlS

[Investing News Network Australia (INN) @INN_Australia]

#Technology innovations in the prevention and management of cardiovascular diseases create opportunities for investors to generate wealth through #health. @CardieXLimited #investing https://t.co/pBH81fv1jF

[Investing News Network Australia (INN) @INN_Australia]

SphygmoCor®, @CardieXLimited's groundbreaking #technology, sets the benchmark for vascular biomarkers as the company aims to develop and market technologies and digital solutions focused on the world’s largest health disorders. #investing https://t.co/oxcHlnFnE2

[Cardiex Limited @CardiexLimited]

Meet Sanjeev Bhavnani, MD FACC, Cardiex's first Chief Clinical Officer. His pioneering work includes spearheading programs to develop and validate new technologies, evaluate safety and effectiveness, and integrate data seamlessly into healthcare systems. Welcome to the team.

[Cardiex Limited @CardiexLimited]

Cardiex will host an investor webinar on 24 April 2024 at 9:00am (AEST)/ 23 April 2024 at 4:00pm (PDT). Join CEO Craig Cooper and a panel of Cardiex executives for a review of quarterly results and other corporate updates. $CDX Register: https://t.co/OVEJZWK9a0

[ATCOR @AtcorMedical]

RT @CardiexLimited: Leo Rosenbaum recently spoke with Cardiex CEO Craig Cooper about 2 major company milestones: the completion of the HEAR…

[North American Artery Society @NAASociety]

Thank you to our newest gold sponsor, @CardieXLimited Join them at the 2024 NAA Conference, June 14-15, 2024 in Aurora, Colorado. See our great lineup of speakers and sign up today https://t.co/MMBVu3u6Ei